Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
AMLX

Updated 10/6/2026, 9:41 AM ET.

AMLX

Amylyx Pharmaceuticals, Inc.

Sale$324,868

Bedrosian Camille L

Chief Medical Officer

10,028 shat $32.40Filed Sep 14, 4:00 PM ETFiling
AMLX

Amylyx Pharmaceuticals, Inc.

Sale$349,821

FRATES JAMES M

Chief Financial Officer

10,810 shat $32.36Filed Sep 14, 4:00 PM ETFiling
AMLX

Amylyx Pharmaceuticals, Inc.

Sale$309,506

Mazzariello Gina

Chief Legal Officer

9,536 shat $32.46Filed Sep 14, 4:00 PM ETFiling
AMLX

Amylyx Pharmaceuticals, Inc.

Sale$980,263

Klee Justin B.

Co-Chief Executive Officer, Director

30,464 shat $32.18Filed Sep 14, 4:00 PM ETFiling
AMLX

Amylyx Pharmaceuticals, Inc.

Sale$980,504

Cohen Joshua B

Co-Chief Executive Officer, Director

30,464 shat $32.19Filed Sep 14, 4:00 PM ETFiling
AMLX

Amylyx Pharmaceuticals, Inc.

Sale$538,868

Mazzariello Gina

Chief Legal Officer

30,000 shat $17.96Filed Jul 13, 4:00 PM ET
Filing

Read from public SEC filings. Not financial advice.